FDA Approved: DEFEROXAMINE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Deferoxamine Mesylate (Deferoxamine) from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Iron Poisoning
• Thalassemia Major
• Transfusional Iron Overload

Drugs mentioned

• Deferoxamine Mesylate (Deferoxamine)

Snippet

SUPPL AP for DEFEROXAMINE (DEFEROXAMINE MESYLATE)